- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04762368
Learning Study: Improving Vision in Adults With Macular Degeneration
Improving Vision in Adults With Macular Degeneration, Study 2: The Effect of Concurrent Perceptual Learning and Brain Stimulation
The purpose of this study is to test whether a kind of brain stimulation called anodal transcranial direct current stimulation (a-tDCS) can be combined with perceptual learning to improve the ability of people with age-related macular degeneration (AMD) or juvenile macular degeneration (JMD) to read words presented to them on a computer screen better than if perceptual learning alone were used.
In addition, secondary measures of visual acuity will also be examined to determine whether brain stimulation can allow patients to resolve finer details of an image. The proposed treatment is the application of a-tDCS onto the participant's head, with brain stimulation aimed at Primary Visual Cortex toward the occipital pole, while patients undergo six separate sessions of training. The investigators will test the ability of participants to read words before the start of the training sessions (pre test) and after the completion of all training sessions (post test). This is a between-subjects design, and half of the participants will receive true stimulation, and the other half will receive sham stimulation. The difference between the pre and post tests when receiving active stimulation will be compared to the difference when receiving sham stimulation, because the sham stimulation is not expected to influence reading beyond a placebo. The aim of the study is to examine the potential of concurrent brain stimulation and perceptual learning as an effective treatment for macular degeneration that may be used in conjunction with more traditional eye-based interventions. The investigators hypothesize that the brain stimulation will enable higher performance in the reading task after and secondary measures after perceptual training due to an increase in the cortical excitability of the stimulated brain cells.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be carried out in Ontario, Canada (University of Waterloo) and Hong Kong (The Hong Kong Polytechnic University). There are two conditions: Active brain stimulation + perceptual training and sham/placebo brain stimulation + perceptual training. This study uses a between-subjects design, such that half of all participants will be placed in the active stimulation group and half will be placed in the sham group.
Participants will be recruited from university-affiliated clinics and local clinical practices. Following full informed consent, participants will complete baseline testing and clinical testing to confirm that they meet eligibility criteria including: a diagnosis of macular degeneration without any additional eye disease, impaired vision but with enough visual acuity that the computer monitor can still present readable word, and no contraindications for brain stimulation interventions. Eligible participants will then be randomized to either receiving the active stimulation during perceptual training or the placebo stimulation during perceptual training.
The primary outcome measure is verbal reading accuracy for sentences presented on a computer screen following a Rapid Serial Visual Presentation (RSVP) task in which a single word is presented on the screen at a time. Participants will freely observe the words and will indicate the words on the screen verbally. The secondary outcome measures are contrast sensitivity and crowded and uncrowded visual acuity as measured by Freiburg Visual Acuity & Contrast Test (FrACT) using the Landolt C stimulus. The "C"'s gap will be oriented randomly, and the participant will indicate the orientation of the stimulus. Crowded visual acuity will be assessed with Landolt C surrounded by a solid ring, while uncrowded visual acuity will be assessed with the Landolt C alone. The Test of contrast sensitivity will measure the amount of contrast required relative to the background to identify the orientation of the "C". The Hong Kong Polytechnic University has an additional set of secondary outcome measures of temporal and spatial visual span. Temporal visual span will be assessed using Chinese trigrams presented horizontally or vertically at the centre for a range of presentation times. Spatial visual span will be assessed using Chinese trigrams presented horizontally or vertically at different character positions for a fixed presentation time. Participants will be asked to recognize all three characters in a correct order.
The study consists of 9 sessions plus 1 additional session particularly for Hong Kong Polytechnic University
Session 0: This session only applies for The Hong Kong Polytechnic university, that horizontal and vertical temporal and spatial visual span will be collected.
Session 1: The first session will include the clinical evaluation. In addition, the pre tests of all outcome measures will be collected (RSVP performance, crowded and uncrowded visual acuity, contrast sensitivity).
Sessions 2-7: Brain stimulation sessions. Participants will undergo roughly 1 hour of perceptual training, performing the RSVP task. The first 25 minutes of this training will include either sham or active brain stimulation. A given participant will receive the same kind of stimulation for all 6 training sessions.
Session 8: No brain stimulation will occur. Post test outcome measures will be collected (RSVP performance, crowded and uncrowded visual acuity, contrast sensitivity, horizontal and vertical temporal and spatial visual span).
Session 9: 30 day follow up. 30 days after the final training session, participants will again perform the outcome measures without brain stimulation to determine the long term benefit of the perceptual training + brain stimulation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ben Thompson, PhD
- Phone Number: 39398 15198884567
- Email: ben.thompson@uwaterloo.ca
Study Contact Backup
- Name: Andrew E Silva, PhD
- Email: a8silva@uwaterloo.ca
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Recruiting
- University of Waterloo
-
Contact:
- Andrew E Silva, PhD
- Email: a8silva@uwaterloo.ca
-
-
-
-
Kowloon
-
Hung Hom, Kowloon, Hong Kong
- Recruiting
- The Hong Kong Polytechnic University
-
Contact:
- Allen Cheong, PhD
- Email: allen.my.cheong@polyu.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of AMD (age 60+) or JMD (current age 18+).
- Visual acuity (VA); between 6/9-6/96 in the better eye
- Best-corrected near visual acuity of 4.0M at 40 cm or better in the better eye
- Stable vision in previous 3 months (patient report)
- Central vision loss
Exclusion Criteria:
- Diagnosed dementia.
- Not fluent in reading English (Waterloo) or Chinese characters (Hong Kong).
- Any ocular surgery (including anti-vegF injections) within the duration of the study, except for: A. Chronic and continuous injections for at least 1 year. B. Injections stopped at least 2 months before participation. C. Injections in the untested eye
- Ocular pathology other than JMD or AMD that can significantly reduce central vision. Example: mild cataract of grade 2 or below is acceptable
- Severe hearing impairment.
- Contraindications for brain stimulation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active + Training
Participants in this arm will be exposed to active stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
|
a weak electric current is applied to the head through electrodes to affect the cortical excitability of the targeted cells in the brain.
|
|
Sham Comparator: Sham + Training
Participants in this arm will be exposed to sham stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
|
The tDCS machine will be used as in active stimulation, except the electrical current will not be applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Rapid Serial Visual Presentation (RSVP) Reading performance before and right after training.
Time Frame: The pre test and post test will take roughly 1 hour to complete, and they will be roughly 4-7 weeks apart.
|
Behavioral Measure - Participants will verbally read words presented on a computer.
A variety of speeds and sizes will be presented, so that an accurate measure of the maximum reading speed, and the smallest text size readable at the maximum reading speed can be calculated.
The maximum reading speed and smallest text size will be measured before and after training.
The outcome measures are the change in these reading measurements from pre test to post test.
|
The pre test and post test will take roughly 1 hour to complete, and they will be roughly 4-7 weeks apart.
|
|
Change in Rapid Serial Visual Presentation (RSVP) Reading performance 30 days after training
Time Frame: The test will take roughly 1 hour to complete, and they will be roughly 7-10 weeks apart.
|
Behavioral Measure - Participants will verbally read words presented on a computer.
A variety of speeds and sizes will be presented, so that an accurate measure of the maximum reading speed, and the smallest text size readable at the maximum reading speed can be calculated.
The maximum reading speed and smallest text size will be measured before and after training.
The outcome measures are the change in these reading measurements from pre test to the 30 day follow up.
|
The test will take roughly 1 hour to complete, and they will be roughly 7-10 weeks apart.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Uncrowded Visual Acuity before and just after training
Time Frame: The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 4-7 weeks apart.
|
Visual acuity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html .
The outcome measure is the change in performance from pre test to the post test
|
The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 4-7 weeks apart.
|
|
Change in Uncrowded Visual Acuity before and 30 days after training
Time Frame: The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 7 to 10 weeks apart.
|
Visual acuity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html .
The outcome measure is the change in performance from pre test to the 30 day follow up.
|
The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 7 to 10 weeks apart.
|
|
Change in Crowded Visual Acuity before and just after training
Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart.
|
Visual acuity as measured by participants indicating the orientation of the gap present in a Crowded (Ring) Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html .
The outcome measure is the change in performance from pre test to post test.
|
The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart.
|
|
Change in Crowded Visual Acuity before and 30 days after training
Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 7 - 10 weeks apart.
|
Visual acuity as measured by participants indicating the orientation of the gap present in a Crowded (Ring) Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html .
The outcome measure is the change in performance from pre test to the 30 day follow up.
|
The tests will take roughly 5 minutes to complete, and they will be roughly 7 - 10 weeks apart.
|
|
Change in Contrast Sensitivity before and just after training
Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart.
|
Contrast sensitivity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html .
The outcome measure is the change in performance from pre test to the post test.
|
The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart.
|
|
Change in Contrast Sensitivity before and 30 days after training
Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 7-10 weeks apart.
|
Contrast sensitivity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html .
The outcome measure is the change in performance from pre test to the 30 day follow up.
|
The tests will take roughly 5 minutes to complete, and they will be roughly 7-10 weeks apart.
|
|
Change in Temporal Visual Span before and just after training
Time Frame: The test will take roughly 1.5 hours to complete, and they will be roughly 5-8 weeks apart
|
Three unrelated Chinese characters will appear at the centre of a monitor for a range of exposure times.
Participants will be asked to recognize all three characters in a correct order.
Both horizontal and vertical presentation will be assessed.
The outcome measures are the changes in time for recognizing the characters from pre test to the post test.
|
The test will take roughly 1.5 hours to complete, and they will be roughly 5-8 weeks apart
|
|
Change in Spatial Visual Span before and just after training
Time Frame: The test will take roughly 1.5 hours to complete, and they will be roughly 5-8 weeks apart.
|
Three unrelated Chinese character will appear at different character positions for a fixed exposure time, while participants will be asked to keep fixation at the centre but recognize all three characters in a correct order.
Both horizontal and vertical presentation will be assessed.
The outcome measures are the changes in the size of the spatial visual span from pre test to the post.
|
The test will take roughly 1.5 hours to complete, and they will be roughly 5-8 weeks apart.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ben Thompson, PhD, University of Waterloo
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VSBrainStim2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Macular Degeneration
-
Novartis PharmaceuticalsTerminatedNeovascular Age-Related Macular DegenerationRussian Federation
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationSpain, Italy, Germany, Canada, Ireland
-
Hoffmann-La RocheWithdrawnNeovascular Age-Related Macular DegenerationDenmark, Argentina, Hong Kong, Thailand, Portugal, Greece, Spain
-
Regeneron PharmaceuticalsCompletedNeovascular Age Related Macular DegenerationUnited States
-
Hui PengNot yet recruitingNeovascular Age-related Macular Degeneration(nAMD)
-
Rophibio, Inc.Not yet recruitingNeovascular Age-related Macular Degeneration (nAMD)United States
-
Centre Hospitalier Intercommunal CreteilCompletedMacular Degeneration Exudative Eye Left | Macular Degeneration Exudative Eye RightFrance
-
University of Modena and Reggio EmiliaCompletedMacular Degeneration Advanced | Macular Degeneration, Dry | Macular Degeneration, Senile | Macular Scar | Macular Degeneration NonexudativeItaly
-
Shanghai General Hospital, Shanghai Jiao Tong University...Innostellar Biotherapeutics Co.,LtdRecruitingNeovascular Age-related Macular DegenerationChina
-
Shanghai Refreshgene Technology Co., Ltd.RecruitingNeovascular Age-related Macular DegenerationChina
Clinical Trials on Active anodal tDCS
-
The University of Texas at DallasWithdrawn
-
University of WaterlooThe Hong Kong Polytechnic UniversityCompleted
-
The University of Texas at DallasCompleted
-
The University of Texas at DallasCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
The University of Texas at DallasCompleted
-
The University of Texas at DallasCompleted
-
Neuromed IRCCSCompletedPostdural Puncture Headache | Lumbar PunctureItaly
-
Hôpital le VinatierCompletedSchizophrenia | Auditory HallucinationsFrance, Tunisia
-
Stephane ARMANDLa Tour Hospital; School of Health Sciences GenevaRecruitingChronic Low Back PainSwitzerland
-
University of SalernoCompletedProgressive Supranuclear Palsy | Motor and Cognitive SymptomsItaly